louisiana glp-1 pancreatitis lawsuit Ozempic [2026 Update] Patients claim blindness, bowel injuries
Description
Accessed July 22, 2024.
![louisiana glp-1 pancreatitis lawsuit Ozempic [2026 Update] Patients claim blindness, bowel injuries](https://bloximages.chicago2.vip.townnews.com/centraloregondaily.com/content/tncms/assets/v3/editorial/6/d4/6d4e52c1-434b-4c3b-92fc-3285d2be372b/698a36688afad.image.jpg?crop=1676%2C944%2C3%2C20&resize=888%2C500&order=crop%2Cresize)
These findings suggest GLP-1s could be a helpful tool not just for weight loss, but also for those managing addictive behaviors and striving for sustained recovery
![louisiana glp-1 pancreatitis lawsuit Ozempic [2026 Update] Patients claim blindness, bowel injuries](https://www.atraxialaw.com/uploads/mdl-3094.jpg?w=550&q=70&zc=1)
Overall, indirect comparisons suggest that SGLT2 inhibitors may offer greater preservation of eGFR than GLP-1 receptor agonists in a broader population of people with type 2 diabetes mellitus and CKD
![louisiana glp-1 pancreatitis lawsuit Ozempic [2026 Update] Patients claim blindness, bowel injuries](https://simonlawpc.com/wp-content/uploads/2024/08/ozempic.webp)
Its Not Willpower
The most common side effects include nausea, upset stomach, constipation, fatigue, and headaches, which typically resolve with time
![louisiana glp-1 pancreatitis lawsuit Ozempic [2026 Update] Patients claim blindness, bowel injuries](https://www.seegerweiss.com/wp-content/uploads/2023/10/AdobeStock_501320442-1-scaled.jpeg)
Targeted Wellness: Tirzepatide, Supporting Peptides, and the Evolving Approach to Weight Management June 19, 2025 Revolutio nizing Weight Loss with GLP-1 Medications at ATX Infusion The growing interest in GLP-1 receptor medications like Tirzepatide signals a major shift in how we approach weight loss and metabolic health